MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Orthofix Medical DPO Ratio 2011-2026 | OFIX
Annual DPO Ratio Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.3 | 77.1 | 60.2 | 79.9 | 78.7 | 41.4 | 72.1 | 68 | 71.1 | 59.6 | 69.1 | 48.8 | 73.8 | 92 | 52.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 92 | 41.4 | 68.1 |
Quarterly DPO Ratio Orthofix Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.3 | 64.8 | 59.5 | - | 72.2 | 76.8 | 85.9 | - | 74.3 | 65.8 | 51.7 | - | 41.8 | 39.6 | 86.8 | - | 63.7 | 68.4 | 77.8 | - | 80.4 | 91.1 | 83.8 | 69.3 | 72.9 | 70.3 | 72.9 | 64.1 | 68.3 | 71.9 | 68.2 | 60.9 | 60.5 | 71.3 | 65.6 | 56.2 | 65.9 | 58.2 | 63.4 | 69.9 | 62.7 | 68.3 | 69.9 | 56.2 | 47.8 | 47.5 | 57.8 | 55.3 | 75.3 | 86.2 | 76.4 | 77 | 82.8 | 81.2 | 75.7 | 58 | 65.1 | 73.4 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 91.1 | 39.6 | 68.1 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
52.3 | $ 3.72 | 0.95 % | $ 153 M |  USA |
 |
AxoGen
AXGN
|
34.4 | $ 33.03 | -4.08 % | $ 1.52 B | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.07 | -1.09 % | $ 862 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 12.25 | 1.79 % | $ 1.66 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 36.66 | -0.27 % | $ 5.46 K | USA |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 62.57 | -0.4 % | $ 92.6 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 9.41 | 0.48 % | $ 266 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 34.54 | -0.72 % | $ 1.07 B | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.62 | 5.64 % | $ 38.6 M | USA |
 |
Delcath Systems
DCTH
|
56 | $ 9.76 | 1.35 % | $ 350 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.5 | 3.24 % | $ 131 M |  France |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 81.26 | 0.26 % | $ 47.5 B | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.6 | 0.04 % | $ 122 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Align Technology
ALGN
|
33.7 | $ 170.52 | -0.05 % | $ 12.8 B | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 1.87 | 0.27 % | $ 1.14 M | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.31 | -2.31 % | $ 717 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Inogen
INGN
|
34.6 | $ 6.42 | 3.38 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 0.99 | 1.47 % | $ 16.8 M | USA |
 |
IRadimed Corporation
IRMD
|
34.8 | $ 96.6 | 0.38 % | $ 1.23 B | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 85.01 | -2.12 % | $ 2.95 B | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.95 | -0.68 % | $ 374 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
LENSAR
LNSR
|
146 | $ 5.97 | -1.49 % | $ 71.4 M | USA |
 |
Pulmonx Corporation
LUNG
|
60.4 | $ 1.38 | 3.38 % | $ 56.1 M | USA |
 |
Medtronic PLC
MDT
|
76.2 | $ 86.52 | -0.13 % | $ 111 B | USA |
 |
MiMedx Group
MDXG
|
54.8 | $ 3.89 | -0.89 % | $ 575 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Myomo
MYO
|
34.8 | $ 0.69 | 3.22 % | $ 28.9 M | USA |